| __timestamp | Teva Pharmaceutical Industries Limited | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 9216000000 | 125883000 |
| Thursday, January 1, 2015 | 8296000000 | 69036000 |
| Friday, January 1, 2016 | 10044000000 | 72700000 |
| Sunday, January 1, 2017 | 11560000000 | 105700000 |
| Monday, January 1, 2018 | 10558000000 | 198700000 |
| Tuesday, January 1, 2019 | 9351000000 | 117600000 |
| Wednesday, January 1, 2020 | 8933000000 | 108100000 |
| Friday, January 1, 2021 | 8284000000 | 122500000 |
| Saturday, January 1, 2022 | 7952000000 | 146700000 |
| Sunday, January 1, 2023 | 8200000000 | 257500000 |
| Monday, January 1, 2024 | 8480000000 |
Infusing magic into the data realm
In the competitive landscape of pharmaceuticals, cost efficiency is paramount. This analysis delves into the cost of revenue trends for Teva Pharmaceutical Industries Limited and United Therapeutics Corporation from 2014 to 2023. Over this period, Teva's cost of revenue fluctuated, peaking in 2017 with a 25% increase from 2015, before declining by 31% by 2022. In contrast, United Therapeutics maintained a more stable trajectory, with a notable 104% increase in 2023 compared to 2014. This divergence highlights Teva's challenges in managing costs, while United Therapeutics demonstrates a more consistent approach. The data underscores the importance of strategic cost management in sustaining competitive advantage in the pharmaceutical industry. As the sector evolves, these insights offer a glimpse into the financial strategies that can drive success.
Sanofi vs United Therapeutics Corporation: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Teva Pharmaceutical Industries Limited
Cost of Revenue Trends: Teva Pharmaceutical Industries Limited vs Pharming Group N.V.
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and Lantheus Holdings, Inc.
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Veracyte, Inc.
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Amphastar Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: United Therapeutics Corporation vs Insmed Incorporated
Cost Insights: Breaking Down United Therapeutics Corporation and Dr. Reddy's Laboratories Limited's Expenses
Cost of Revenue: Key Insights for United Therapeutics Corporation and Bausch Health Companies Inc.
Cost of Revenue Comparison: United Therapeutics Corporation vs Supernus Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for United Therapeutics Corporation and Galapagos NV